Onconetix announces 1-for-40 reverse stock split

Onconetix announced that the Company’s stockholders have approved all proposals voted on at the Company’s 2024 annual meeting of stockholders held on September 5, 2024, and that its Board of Directors approved a 1-for-40 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on Tuesday, September 24, 2024.